Prevalence of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma in Upper Egypt by Shazly, Tarek A et al.
Prevalence of Pseudoexfoliation Syndrome and
Pseudoexfoliation Glaucoma in Upper Egypt
Shazly et al.
Shazly et al. BMC Ophthalmology 2011, 11:18
http://www.biomedcentral.com/1471-2415/11/18 (27 June 2011)RESEARCH ARTICLE Open Access
Prevalence of Pseudoexfoliation Syndrome and
Pseudoexfoliation Glaucoma in Upper Egypt
Tarek A Shazly
1,2*, Abdelsattar N Farrag
3, Asmaa Kamel
3 and Ashraf K Al-Hussaini
1,3
Abstract
Background: Pseudoexfoliation (PXF) is a recognized risk factor for developing cataract, glaucoma and lens
dislocation. PXF is also associated with increased risk of complications during cataract surgery due to poor
mydriasis and zonular weakness. The aim of this study is to report the prevalence of pseudoexfoliation among
Upper Egyptians attending the ophthalmology clinic of Assiut University Hospital.
Methodology: A retrospective, chart review study conducted in the period from February 2002 to August 2009. A
total of 7738 patients aged 40 years or older attending the general ophthalmic clinics were included in this study.
A detailed evaluation including ophthalmic and general history, slit lamp biomicroscopy, intraocular pressure
measurement, gonioscopy and dilated eye examination were performed. Patients with pseudoexfoliative material
on the anterior lens surface and ⁄ or the pupillary margin in either or both eyes were labeled as having PXF.
Results: Out of the 7738 patients included, three hundred twenty (4.14%) subjects had PXF. Mean age of PXF
group was 68.15 years (SD 8.16, range 40-92 years). PXF was bilateral in 82.2% of cases. It was significantly
associated with cataract, glaucoma and hearing loss. Of the PXF patients, 65% had cataract, 30.3% had glaucoma
and 8.1% had hearing loss.
Conclusion: Pseudoexfoliation appears to be a common disorder in older individuals in Upper Egypt.
Background
Pseudoexfoliation syndrome (PXF) was first reported by
Lindberg in 1917 in a Finnish population [1]. It is char-
acterized by the deposition of a distinctive fibrillar mate-
rial in the anterior segment of the eye. Pseudoexfoliation
syndrome is frequently associated with open angle glau-
coma, known as pseudoexfoliation glaucoma, which is
the most common identifiable form of secondary open
a n g l eg l a u c o m aw o r l d w i d e[ 2 ]. Pseudoexfoliation is a
known risk factor for developing cataracts [3]. Compli-
cating factors such as poor mydriasis, zonular weakness,
corneal endothelial dysfunction, higher rate of vitreous
loss, capsular phimosis, and opacification have all been
reported after cataract surgery [4,5]. Pseudoexfoliation is
considered to be a systemic disorder, pseudoexfoliative
material has been reported in lungs, skin, liver, heart,
kidney, gallbladder, blood vessels, extra ocular muscles
and meninges [6]. An association between PXF and sen-
sorineural deafness has been reported [7-11].
Pseudoexfoliation is rarely seen before the age of 40,
and its prevalence increases markedly with age [12].
Although it occurs in virtually every area of the world, a
considerable racial variation exists. Framingham study
showed that the prevalence of PXF was 1.8% [13]. In
another study of subjects over 60 years in various ethni-
cities, prevalence rates ranging from 0% in Greenland
Eskimos to 21% in Icelanders were noted [14]. In north-
ern/western European countries including England, Ger-
many, and Norway prevalence of 4.0%, 4.7%, and 6.3%
have been reported respectively [15].
Epidemiological studies of PXF have been done in
some areas in the Middle East, namely in Jordan and
Yemen [16,17], but there is no data available on preva-
lence of PXF in Egypt.
Egypt is one of the most populous countries in Africa
and the Middle East, with a population approaching 80
million. Assiut University Hospital (AUH) is a tertiary
medical centre in Assiut - the most populous governor-
ate of Upper Egypt -which serves a large number of
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hospital-based study is to estimate the prevalence of
PXF, provide a descriptive analysis and to assess
whether PXF is associated with cataract, glaucoma, hear-
ing loss, systemic arterial hypertension and/or diabetes
mellitus.
Methods
The charts of 7738 consecutive patients aged 40 years or
older who attended the general ophthalmic clinics of
Assiut University Hospital in the period from February
2002 to August 2009 were included in this retrospective
study.
The study protocol was approved by the medical
ethics committee of Assiut University.
Relevant details in medical and ocular history were
obtained from each patient including; history of sys-
temic arterial hypertension, diabetes mellitus, hearing
loss, intraocular surgery, visual problems, amblyopia
and use of corrective glasses and/or contact lenses. All
patients underwent complete ocular examination con-
ducted by a senior experienced ophthalmologist (AKA)
included slit lamp biomicroscopy, intraocular pressure
measurement, gonioscopy, and dilated fundus
examination.
Pseudoexfoliation was diagnosed clinically by the pre-
sence of typical pseudoexfoliation material (PXM) at the
pupil border on undilated examination, on anterior lens
capsule on dilated examination, or on the trabecular
meshwork on gonioscopy, with or without Sampaolesi’s
line and pigment deposition in angle and/or corneal
endothelium.
Cataracts were graded at the slit lamp with respect to
nuclear opalescence (NO: 0.1-6.9), nuclear color (NC:
0.1-6.9), cortical (C: 0.1-5.9) and posterior subcapsular
(P: 0.1-5.9) cataract, using the Lens Opacities Classifica-
tion System (LOCS) III [18]. According to the average
LOCS III value (average of NO, NC, C, P), lens opacities
were defined as no cataract (avLOCS<1.5), and cataract
(avLOCS≥1.5).
Diagnosis of glaucoma was made if: intra ocular pres-
sure (IOP) ≥ 22 mm Hg in either eye; vertical cup disc
ratio (VCDR) ≥ 0.7 or a cup disc ratio (CDR) asymmetry
≥ 0.2; and focal thinning, notching, or a splinter hemor-
rhage. Glaucoma was defined based on the International
Society of Geographical and Epidemiologic Ophthalmol-
ogy (ISGEO) classification [19].
Detailed history of diabetes mellitus, systemic arterial
hypertension and hearing loss was specifically obtained
in PXF and non-PXF subjects.
The statistical analysis was performed using the Statis-
tical Program for the Social Sciences Version 16.0
(SPSS, Inc, Chicago, IL, USA).
Means, standard deviations (SDs) and 95% confidence
intervals (CIs) were obtained. A p-value of < 0.05, mea-
sured by Pearson’sc h i - s q u a r et e s t ,w a sc o n s i d e r e dt o
indicate statistical significance.
Multiple logistic regression models were used to
examine the association between PXF with cataract and
glaucoma, while adjusting for gender and age.
Patients were divided into two groups; PXF and non-
PXF. For each group the sex distribution, mean age and
standard deviation (SD) were calculated. The total num-
ber of eyes studied was 7738. The PXF group included
320 eyes and the non-PXF group included 7418 eyes.
Frequencies of cataract, glaucoma and hearing loss in
both groups were estimated.
Results
Out of 7738 patients enrolled, 320 were diagnosed with
PXF. Thus the prevalence of PXF in those ≥40 years
was 4.14%. The age-adjusted prevalence of PXF in those
≥60 years was 6.02 (95% CI: 4.70-7.51) in those ≥60
years of age. We calculated the age-specific standardized
rates of PXF by using the U.S. population as a standard.
Of the 320 PXF patient included, 132 (41.25%) were
female and 188 (58.75%) were male. The association
between PXF and gender was not statistically significant
(p = 0.09).
Mean age in the PXF group was 68.15 years (SD 8.16,
range 40-92 years). Prevalence of PXF increased with
age and was highest among subjects aged > 80 years.
Approximately 90% of all PXF patients were over 60
years old (table 1).
Unilateral PXF was noted in 17.8% of the PXF group
and bilateral PXF was noted in 82.2% (figure 1).
Cataract was found in 65% of eyes with PXF (figure 2),
but in only 42.5% of non-PXF eyes (p < 0.001), indicat-
ing a strong association between cataract and PXF
(Table 2). During the study period, 3289 patients under-
went cataract surgery in one or both eyes, of which
6.32% had PXF.
Glaucoma was found in 30.31% of eyes in the PXF
group, but in only 3.3% of eyes in the non-PXF group.
The association between PXF and glaucoma was statisti-
cally significant (p < 0.001), as shown in Table 2.
Out of the 320 patients, 34 (10.6%) were already diag-
nosed with psedoexfoliation glaucoma and 63 patients
(19.7%) had IOP of more than 21 in one or both eyes
and have not been evaluated for glaucoma before.
Hearing loss was documented in 8.1% of 320 PXF
patients and in only 2.3% of 7418 non-PXF. This asso-
ciation between PXF and hearing loss was statistically
significant (table 2).
Significant corneal opacities were present in 7.9% of
the PXF patients and 6.1% of non-PXF patients. The
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nificant (p > 0.05).
We found no statistically significant association
between PXF and diabetes mellitus (p = 0.18) or sys-
temic arterial hypertension p = 0.25.
Discussion
The reported prevalence rate of PXF syndrome in differ-
ent populations shows extensive variations. Prevalence
rates of as low as 0% in Eskimos [20], and as high as
38% in Navajo Indians [21] were reported.
In a hospital based study conducted in Jordan, the
prevalence of pseudoexfoliation among patients aged 40-
90 years was 9.1% [17]. In another study from Yemen
the point prevalence of PXF among patients undergoing
cataract surgery was 19.53% [16].
To the best of the authors’ knowledge, there are no
previous reports on the prevalence or characteristics of
PXF in Egypt. The prevalence of pseudoexfoliation
among individuals aged 40 years or older in this study is
4.14%.
One of the limitations of this study is being a hospital-
based rather than a population-based study. Over or
under-estimation of the prevalence of PXF and or co-
morbidities associated with PXF may be attributed to
the hospital based nature of the study.
In agreement with findings in other reports, our study
showed an increase in the prevalence of PXF with
advancing age [22-24].
PXF was more common among males (188) than in
females (132). A similar finding was reported in the pre-
valence of PXF among patients undergoing cataract Sur-
gery in Yemen [16]. We found that PXF was bilateral in
the majority of cases (82.2%), comparable to what Tilik-
sew et al. found [24].
A significant association between PXF and cataract
was also found in our study and is compatible with find-
ings in other studies [23,24].
The age-adjusted PXF rate (direct standardization
using the population estimates for the U.S. for the year
2000 as the standard) in our study population for those
40 years of age or older was similar to the age-standar-
dized rates of PXF reported in south India (3.01%)
reported by Thomas et al. [25], in the Chennai study
Table 1 Age and gender distribution of the study group
Age group No of males
studied
Number of male PXF
patients (percentage)
No of females
studied
Number of female PXF
patients (percentage)
p-value*
40-49 43 3 (7%) 24 1 (4.1%) >0.05
50-59 532 13 (2.4%) 360 14 (3.9%) >0.05
60-69 1553 80 (5.2%) 1288 45 (3.5%) >0.05
70-79 1633 70 (4.3%) 1427 59 (4.1%) >0.05
80-89 484 20 (4.1%) 266 11 (4.1%) >0.05
90-99 70 2 (2.9%) 59 2 (3.4%) >0.05
Total 4315 188 (4.35%) 3424 132 (3.9%) >0.05
* Chi Square test.
Figure 1 An eye with pseudoexfoliation showing the dandruff
like pseudoexfoliation material on the surface of the
cataractous lens capsule.
Figure 2 An eye with pseudoexfoliation showing the dandruff
like pseudoexfoliation material on the pupillary edge.
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and higher than the rates in the Framingham Eye Study
(1.9%), [27] and Visual Impairment Study (0.98%) [28].
However, the age-specific standardized PXF rates in
other population-based studies–one from southern India
[29], central Iran [30] and from Crete (Greece) [31,32]–
were high (7.6%, 9.4% and 16.1% respectively) in com-
parison to those in our study.
A strong relationship between glaucoma and PXF is
known [33]. Subjects with PXF had a two- to three-
fold increased risk for glaucoma according to the Blue
Mountains Eye Study [26]. Other studies have demon-
strated that eyes with PXF had higher mean IOP than
eyes without PXF [13,26]. Moreover, Topouzis F et al.
reported increased likelihood of glaucoma at the same
IOP in subjects with PXF [34]. Our study is consis-
tent with the above as we found an increased risk for
glaucoma in patients with PXF. Our finding that
30.31% of eyes with PXF had glaucoma reflects a
comparable proportion to that reported by Al-Bdour
et al. in Jordan [17], yet higher that that found by the
Blue Mountains Eye Study, which found incidences of
14.2% [26]. This finding may reflect an overestima-
tion, which is one of the limitations of hospital-based
studies.
One of the limitations of our study is that hearing loss
was assessed via detailed history taking. Some of the
patients had audiometry documented sensorineural
hearing loss, while others didn’t undergo audiometric
studies.
In our study hearing loss was found in 8.1% of PXF
patients. This association between PXF and hearing loss
was statistically significant (table 2). Cahill et al.
reported that a large proportion of patients with PXF
have sensorineural hearing loss in comparison to age-
matched controls, regardless of whether or not there is
associated glaucoma [7]. This was confirmed by other
studies from different Saudi Arabia, Canada, Turkey and
Iran [8-11]. Furthermore, in a recent study Turgut et al.
reported high prevalence of asymptomatic vestibular
dysfunction among patients with PXF [35].
Although the material reported here has many limita-
tions, it adds some new information on the prevalence
and characteristics of PXF in a region where data on
PXF are scarce.
Conclusion
In conclusion we found the prevalence of PXF among
Upper Egyptian individuals aged 40 years or older to be
4.14%. This rate is similar to other studies conducted in
south India, the Chennai study, and Blue Mountains Eye
Study. Ophthalmologists in Egypt should focus on the
detection of PXF, especially considering the risks for
operative complications related to PXF and the higher
prevalence of glaucoma among PXF patients.
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